210 related articles for article (PubMed ID: 28488449)
1. Role of personalized medication training in improving efficacy and adherence to a topical therapy in psoriatic patients.
Caldarola G; De Simone C; Moretta G; Poscia A; Peris K
J Dermatolog Treat; 2017 Dec; 28(8):722-725. PubMed ID: 28488449
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a fixed combination of calcipotriol/betamethasone dipropionate topical gel in adult patients with mild to moderate psoriasis: blinded interim analysis of a phase IV, multicenter, randomized, controlled, prospective study.
Reich K; Zschocke I; Bachelez H; de Jong EM; Gisondi P; Puig L; Warren RB; Mrowietz U;
J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1156-63. PubMed ID: 25346093
[TBL] [Abstract][Full Text] [Related]
3. Improvement of health-related quality of life and adherence to treatment with calcipotriol-betamethasone dipropionate gel in patients with psoriasis vulgaris.
Kontochristopoulos G; Kouris A; Chantzaras A; Petridis A; Yfantopoulos J
An Bras Dermatol; 2016 Apr; 91(2):160-6. PubMed ID: 27192514
[TBL] [Abstract][Full Text] [Related]
4. Treatment of psoriasis vulgaris with the two-compound product calcipotriol/betamethasone dipropionate followed by different formulations of calcipotriol.
Cassano N; Miracapillo A; Coviello C; Loconsole F; Bellino M; Vena GA
Clin Drug Investig; 2006; 26(4):227-33. PubMed ID: 17163256
[TBL] [Abstract][Full Text] [Related]
5. Topical treatment for scalp psoriasis: Comparison of patient preference, quality of life and efficacy for non-alcoholic mometasone emulsion versus calcipotriol/betamethasone gel in daily clinical practice.
Gual A; Pau-Charles I; Molin S
J Dermatolog Treat; 2016; 27(3):228-34. PubMed ID: 26503824
[TBL] [Abstract][Full Text] [Related]
6. Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: 4- and 12-week interim results from the PRO-long study.
Lambert J; Hol CW; Vink J
J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1723-31. PubMed ID: 24533503
[TBL] [Abstract][Full Text] [Related]
7. A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP).
Reich K; Zschocke I; Bachelez H; de Jong EMGJ; Gisondi P; Puig L; Warren RB; Ortland C; Mrowietz U;
Br J Dermatol; 2017 Jul; 177(1):197-205. PubMed ID: 28301043
[TBL] [Abstract][Full Text] [Related]
8. Patient satisfaction and efficacy of calcipotriol plus betamethasone dipropionate gel in plaque psoriasis patients with poor adherence.
Takahashi H; Katayama H; Uwajima Y; Koda M; Sasaki H; Tanito K; Hagiwara M; Matsuo K; Nakagawa H
J Dermatol; 2020 Nov; 47(11):1249-1256. PubMed ID: 32734661
[TBL] [Abstract][Full Text] [Related]
9. Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: final analysis of the 52-week PRO-long study.
Lambert J; Hol CW; Vink J
J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2349-55. PubMed ID: 26337069
[TBL] [Abstract][Full Text] [Related]
10. Patients with psoriasis have different preferences for topical therapy, highlighting the importance of individualized treatment approaches: randomized phase IIIb PSO-INSIGHTFUL study.
Hong CH; Papp KA; Lophaven KW; Skallerup P; Philipp S
J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1876-1883. PubMed ID: 28796913
[TBL] [Abstract][Full Text] [Related]
11. Real-life treatment profile of calcipotriene and betamethasone dipropionate topical suspension in patients with psoriasis vulgaris.
Bagel J; Levi E; Tyring S; Knuckles ML
J Drugs Dermatol; 2014 Nov; 13(11):1374-9. PubMed ID: 25607705
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
Kragballe K; Hoffmann V; Ortonne JP; Tan J; Nordin P; Segaert S
Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259
[TBL] [Abstract][Full Text] [Related]
13. Treatment adherence and real-life effectiveness of topical therapy in patients with mild or moderate psoriasis: uptake of scientific evidence in clinical practice and dermatologists' preferences for alternative treatment options.
Neri L; Miracapillo A
G Ital Dermatol Venereol; 2015 Feb; 150(1):19-26. PubMed ID: 25521808
[TBL] [Abstract][Full Text] [Related]
14. The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial.
van de Kerkhof PC
Br J Dermatol; 2004 Sep; 151(3):663-8. PubMed ID: 15377355
[TBL] [Abstract][Full Text] [Related]
15. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
Buckley C; Hoffmann V; Shapiro J; Saari S; Cambazard F; Milsgaard M
Dermatology; 2008; 217(2):107-13. PubMed ID: 18463448
[TBL] [Abstract][Full Text] [Related]
16. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
Kircik LH
J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
[TBL] [Abstract][Full Text] [Related]
17. Practicability of combined treatment with calcipotriol/betamethasone gel (Daivobet® Gel) and improvement of quality of life in patients with psoriasis.
Sticherling M; Eicke C; Anger T
J Dtsch Dermatol Ges; 2013 May; 11(5):420-7. PubMed ID: 23437972
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
[TBL] [Abstract][Full Text] [Related]
19. A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study.
Thaçi D; Ortonne JP; Chimenti S; Ghislain PD; Arenberger P; Kragballe K; Saurat JH; Khemis A; Sprøgel P; Esslinger HU; Unnebrink K; Kupper H
Br J Dermatol; 2010 Aug; 163(2):402-11. PubMed ID: 20377585
[TBL] [Abstract][Full Text] [Related]
20. Expert recommendations: the use of the fixed combination calcipotriol and betamethasone dipropionate gel for the topical treatment of psoriasis.
Daudén E; Bewley A; Lambert J; Girolomoni G; Cambazard F; Reich K
J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():22-32. PubMed ID: 24684740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]